![Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study | Cardiovascular Diabetology | Full Text Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-016-0375-8/MediaObjects/12933_2016_375_Fig4_HTML.gif)
Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study | Cardiovascular Diabetology | Full Text
![Steam billows from the cooling towers of Doel's nuclear plant, near Antwerp August 22, 2012. GDF Suez's Belgian unit, Electrabel, will find it difficult to prove its Doel 3 nuclear reactor is Steam billows from the cooling towers of Doel's nuclear plant, near Antwerp August 22, 2012. GDF Suez's Belgian unit, Electrabel, will find it difficult to prove its Doel 3 nuclear reactor is](https://c8.alamy.com/comp/2CYEG3Y/steam-billows-from-the-cooling-towers-of-doels-nuclear-plant-near-antwerp-august-22-2012-gdf-suezs-belgian-unit-electrabel-will-find-it-difficult-to-prove-its-doel-3-nuclear-reactor-is-safe-enough-to-operate-belgian-regulator-fanc-said-last-week-raising-the-prospect-that-the-30-year-old-unit-could-stay-shut-for-good-reutersfrancois-lenoir-belgium-tags-energy-environment-business-2CYEG3Y.jpg)
Steam billows from the cooling towers of Doel's nuclear plant, near Antwerp August 22, 2012. GDF Suez's Belgian unit, Electrabel, will find it difficult to prove its Doel 3 nuclear reactor is
![Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non–ST-Elevation Acute Coronary Syndrome | Circulation Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non–ST-Elevation Acute Coronary Syndrome | Circulation](https://www.ahajournals.org/cms/asset/bc5df24b-0978-4832-a7dc-f13a5bb72395/11ff1.jpeg)
Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non–ST-Elevation Acute Coronary Syndrome | Circulation
![JCM | Free Full-Text | Growth Differentiation Factor-15 (GDF-15) Is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients | HTML JCM | Free Full-Text | Growth Differentiation Factor-15 (GDF-15) Is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients | HTML](https://www.mdpi.com/jcm/jcm-08-01576/article_deploy/html/images/jcm-08-01576-g001-550.jpg)
JCM | Free Full-Text | Growth Differentiation Factor-15 (GDF-15) Is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients | HTML
![PDF) Growth Differentiation Factor-15 (GDF-15) a Precursory Biomarker for Diabetic Patients with Coronary Artery and Chronic Kidney Disease PDF) Growth Differentiation Factor-15 (GDF-15) a Precursory Biomarker for Diabetic Patients with Coronary Artery and Chronic Kidney Disease](https://i1.rgstatic.net/publication/320283172_Growth_Differentiation_Factor-15_GDF-15_a_Precursory_Biomarker_for_Diabetic_Patients_with_Coronary_Artery_and_Chronic_Kidney_Disease/links/59db633a458515b9fa49d1a3/largepreview.png)
PDF) Growth Differentiation Factor-15 (GDF-15) a Precursory Biomarker for Diabetic Patients with Coronary Artery and Chronic Kidney Disease
![PDF) Growth Differentiation Factor-15 (GDF-15) Is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients PDF) Growth Differentiation Factor-15 (GDF-15) Is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients](https://www.researchgate.net/publication/336201509/figure/fig1/AS:809358644486148@1569977546370/Correlations-between-clinical-data-age-eGFR-and-serum-concentrations-of-GDF-15-TNF-a_Q320.jpg)
PDF) Growth Differentiation Factor-15 (GDF-15) Is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients
![Frontiers | Neuromuscular Development and Disease: Learning From in vitro and in vivo Models | Cell and Developmental Biology Frontiers | Neuromuscular Development and Disease: Learning From in vitro and in vivo Models | Cell and Developmental Biology](https://www.frontiersin.org/files/Articles/764732/fcell-09-764732-HTML/image_m/fcell-09-764732-g001.jpg)
Frontiers | Neuromuscular Development and Disease: Learning From in vitro and in vivo Models | Cell and Developmental Biology
![Steam billows from the cooling towers of the Doel nuclear plant of Electrabel, the Belgian unit of French company Engie, former GDF Suez, in Doel near Antwerp, Belgium, January 4, 2016. REUTERS/Francois Steam billows from the cooling towers of the Doel nuclear plant of Electrabel, the Belgian unit of French company Engie, former GDF Suez, in Doel near Antwerp, Belgium, January 4, 2016. REUTERS/Francois](https://c8.alamy.com/comp/2E6MDEB/steam-billows-from-the-cooling-towers-of-the-doel-nuclear-plant-of-electrabel-the-belgian-unit-of-french-company-engie-former-gdf-suez-in-doel-near-antwerp-belgium-january-4-2016-reutersfrancois-lenoir-2E6MDEB.jpg)
Steam billows from the cooling towers of the Doel nuclear plant of Electrabel, the Belgian unit of French company Engie, former GDF Suez, in Doel near Antwerp, Belgium, January 4, 2016. REUTERS/Francois
![Abstract 12644: Growth Differentiation Factor-15 (GDF-15) for Risk Stratification in Patients After an Acute Coronary Syndrome: Insights From the SOLID-TIMI 52 trial | Circulation Abstract 12644: Growth Differentiation Factor-15 (GDF-15) for Risk Stratification in Patients After an Acute Coronary Syndrome: Insights From the SOLID-TIMI 52 trial | Circulation](https://www.ahajournals.org/cms/asset/18a43778-d696-4194-96be-f0ed96f30d96/g12644.jpg)
Abstract 12644: Growth Differentiation Factor-15 (GDF-15) for Risk Stratification in Patients After an Acute Coronary Syndrome: Insights From the SOLID-TIMI 52 trial | Circulation
![Growth-Differentiation Factor-15 for Long-Term Risk Prediction in Patients Stabilized After an Episode of Non–ST-Segment–Elevation Acute Coronary Syndrome | Circulation: Cardiovascular Genetics Growth-Differentiation Factor-15 for Long-Term Risk Prediction in Patients Stabilized After an Episode of Non–ST-Segment–Elevation Acute Coronary Syndrome | Circulation: Cardiovascular Genetics](https://www.ahajournals.org/cms/asset/d5f5e0b1-9e15-4824-8f6d-5f07ab2a4790/13ff5.jpeg)
Growth-Differentiation Factor-15 for Long-Term Risk Prediction in Patients Stabilized After an Episode of Non–ST-Segment–Elevation Acute Coronary Syndrome | Circulation: Cardiovascular Genetics
Galectin-3, GDF-15, and sST2 for the assessment of disease severity and therapy response in patients suffering from inoperable chronic thromboembolic pulmonary hypertension: Biomarkers: Vol 25, No 7
![JCM | Free Full-Text | Growth Differentiation Factor-15 (GDF-15) Is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients | HTML JCM | Free Full-Text | Growth Differentiation Factor-15 (GDF-15) Is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients | HTML](https://www.mdpi.com/jcm/jcm-08-01576/article_deploy/html/images/jcm-08-01576-g002.png)
JCM | Free Full-Text | Growth Differentiation Factor-15 (GDF-15) Is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients | HTML
![Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study | Cardiovascular Diabetology | Full Text Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-016-0375-8/MediaObjects/12933_2016_375_Fig1_HTML.gif)
Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study | Cardiovascular Diabetology | Full Text
![Alvo Modern Glam Round Mirrored Side Table with Tapered Legs | Mirrored end table, Dining table price, Side table wood Alvo Modern Glam Round Mirrored Side Table with Tapered Legs | Mirrored end table, Dining table price, Side table wood](https://i.pinimg.com/564x/15/02/19/150219d49a00558546457428356b4cdd.jpg)
Alvo Modern Glam Round Mirrored Side Table with Tapered Legs | Mirrored end table, Dining table price, Side table wood
![PDF) Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction PDF) Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction](https://i1.rgstatic.net/publication/23938838_Growth_differentiation_factor-15_as_a_prognostic_marker_in_patients_with_acute_myocardial_infarction/links/56685f2208ae8d6928fb1f65/largepreview.png)
PDF) Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction
![PDF) Growth Differentiation Factor-15 (GDF-15) Is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients PDF) Growth Differentiation Factor-15 (GDF-15) Is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients](https://i1.rgstatic.net/publication/336201509_Growth_Differentiation_Factor-15_GDF-15_Is_a_Biomarker_of_Muscle_Wasting_and_Renal_Dysfunction_in_Preoperative_Cardiovascular_Surgery_Patients/links/5d93f436299bf10cff1f5c52/largepreview.png)
PDF) Growth Differentiation Factor-15 (GDF-15) Is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients
![JCM | Free Full-Text | Growth Differentiation Factor-15 (GDF-15) Is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients | HTML JCM | Free Full-Text | Growth Differentiation Factor-15 (GDF-15) Is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients | HTML](https://www.mdpi.com/jcm/jcm-08-01576/article_deploy/html/images/jcm-08-01576-g003.png)